OmniAb, Inc. OABI 深 沪
已收盘 05-08 16:00:00 美东时间
1.66
+0.190
+12.93%
华盛通- 最 高1.69
- 今 开1.54
- 成交量 566.50万股
- 最 低 1.52
- 昨 收 1.47
- 总市值 2.41亿
- 52周最高 2.295
- 市盈率 静 --
- 换手率 3.91%
- 52周最低 1.22
- 委 比 -72.28%
- 总股本 1.45亿
- 历史最高 10.87
- 量 比 13.29
- 振 幅 11.56%
- 历史最低 1.22
- 每 手 1
- 风险率 0.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多OmniAb forecasts $28M-$33M 2026 revenue as partner milestones lift outlook
Earnings Call Insights: OmniAb, Inc. (OABI) Q1 2026 Management view "OmniAb delivered a very strong start to the year, largely driven by advancement of our partner programs," said President, CEO & Dir...
05-08 11:02
电话会总结 ｜ OmniAb(OABI)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据OmniAb业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2025年全年营收为1,870万美元，较2024年的2,640万美元下降29.2%。营收下降主要由于许可费和里程碑付款收入减少，但部分被Exploration平台带来的80万美元收入所抵消。 **盈利状况：** 2025年净亏损为6,480万美元（每股亏损0.57美元），较2024年净亏损6,200万美元（每股亏损0.61美元）略有扩大。如扣除第四季度390万美元的非现金减值费用，每股亏损将为0.54美元。 **运营费用：** 2025年运营费用为8,76
03-16 14:08
OmniAb publishes corporate overview highlighting 107 active partners and over USD 3 billion in potential milestones
OmniAb publishes corporate overview highlighting 107 active partners and over USD 3 billion in potential milestones OmniAb outlined a business model focused on licensing antibody discovery technologies, with revenue streams that can include upfront access fees, milestones and royalties on commercial
03-09 20:10
OmniAb Sees FY2026 Sales $25.000M-$30.000M vs $31.996M Est
OmniAb (NASDAQ:OABI) sees FY2026 sales of $25.000 million-$30.000 million vs $31.996 million analyst estimate.
03-05 05:08
OmniAb Q4 Earnings Assessment
OmniAb (NASDAQ:OABI) released its Q4 earnings on Wednesday, March 4, 2026 at 04...
03-05 05:08
OmniAb Q4 EPS $(0.11) Misses $(0.09) Estimate, Sales $8.376M Miss $9.003M Estimate
OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 23.6 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same
03-05 05:07
Earnings Scheduled For March 4, 2026
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is estimated...
03-04 19:11
A Look Ahead: OmniAb's Earnings Forecast
OmniAb (NASDAQ:OABI) is set to give its latest quarterly earnings report on Wed...
03-04 03:02
OmniAb to Present at Leerink Partners Global Healthcare Conference
OmniAb to Present at Leerink Partners Global Healthcare Conference OmniAb Inc. (NASDAQ: OABI) will participate in the Leerink Partners Global Healthcare Conference, held March 8-11, 2026, at the W South Beach in Miami. The company will present a corporate overview on March 10, 2026 at 3:40 p.m. East
02-24 21:01
OmniAb CFO Kurt Gustafson Reports Disposal of Common Shares
OmniAb CFO Kurt Gustafson Reports Disposal of Common Shares Kurt A. Gustafson, Executive VP, Finance and CFO of OmniAb Inc., reported a disposal of common shares of OmniAb Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUB
02-18 07:21
